Acetazolamide Versus Dapagliflozin in Acute Decompensated Heart Failure Patients

Clinical trial NCT06535529 · RECRUITING

Trial details

NCT number: NCT06535529
Sponsor: Helwan University
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Acute Decompensated Heart Failure

Start date: 2024-08-24
Primary completion: 2025-08-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.